| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma | 38 | 2021 | 318 | 10.500 |
Why?
|
| Retina | 45 | 2022 | 2616 | 5.500 |
Why?
|
| Retinal Neoplasms | 20 | 2016 | 144 | 5.430 |
Why?
|
| Neuroblastoma | 16 | 2022 | 1226 | 3.390 |
Why?
|
| Retinoblastoma Protein | 20 | 2021 | 704 | 3.350 |
Why?
|
| Stem Cells | 22 | 2022 | 3567 | 1.910 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 9 | 2016 | 380 | 1.470 |
Why?
|
| Gene Expression Regulation, Developmental | 17 | 2022 | 3617 | 1.380 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 2020 | 307 | 1.380 |
Why?
|
| Nuclear Proteins | 19 | 2018 | 5853 | 1.340 |
Why?
|
| Xenograft Model Antitumor Assays | 14 | 2020 | 3557 | 1.320 |
Why?
|
| Cell Differentiation | 29 | 2022 | 11483 | 1.230 |
Why?
|
| Rhabdomyosarcoma | 5 | 2022 | 382 | 1.190 |
Why?
|
| Retinal Rod Photoreceptor Cells | 6 | 2019 | 195 | 1.170 |
Why?
|
| Disease Models, Animal | 24 | 2020 | 18029 | 1.020 |
Why?
|
| DNA Helicases | 6 | 2016 | 859 | 0.960 |
Why?
|
| Retinal Bipolar Cells | 3 | 2020 | 47 | 0.950 |
Why?
|
| Organoids | 2 | 2021 | 701 | 0.930 |
Why?
|
| Killer Cells, Natural | 4 | 2020 | 2133 | 0.890 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2022 | 102 | 0.890 |
Why?
|
| Osteosarcoma | 6 | 2019 | 881 | 0.890 |
Why?
|
| Mice | 74 | 2022 | 81183 | 0.830 |
Why?
|
| Epigenesis, Genetic | 11 | 2021 | 3647 | 0.830 |
Why?
|
| Genes, Retinoblastoma | 5 | 2015 | 136 | 0.820 |
Why?
|
| Neurogenesis | 3 | 2022 | 838 | 0.800 |
Why?
|
| Animals | 97 | 2022 | 168757 | 0.790 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2022 | 794 | 0.770 |
Why?
|
| Epigenomics | 6 | 2022 | 903 | 0.760 |
Why?
|
| Gangliosides | 2 | 2019 | 137 | 0.750 |
Why?
|
| Tumor Suppressor Protein p53 | 14 | 2016 | 2948 | 0.750 |
Why?
|
| Cell Cycle | 12 | 2015 | 2967 | 0.720 |
Why?
|
| Euchromatin | 1 | 2019 | 56 | 0.700 |
Why?
|
| Neoplasms | 18 | 2023 | 21683 | 0.690 |
Why?
|
| Cell Division | 12 | 2007 | 4568 | 0.670 |
Why?
|
| Eye | 5 | 2014 | 729 | 0.660 |
Why?
|
| Interleukin-15 | 1 | 2019 | 184 | 0.660 |
Why?
|
| Retinal Degeneration | 4 | 2022 | 415 | 0.640 |
Why?
|
| Synapses | 5 | 2020 | 1728 | 0.630 |
Why?
|
| Topotecan | 2 | 2010 | 137 | 0.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2021 | 8428 | 0.620 |
Why?
|
| alpha-Thalassemia | 1 | 2017 | 46 | 0.580 |
Why?
|
| Homeodomain Proteins | 8 | 2022 | 2421 | 0.580 |
Why?
|
| Heterochromatin | 1 | 2019 | 296 | 0.580 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2017 | 36 | 0.580 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2017 | 4554 | 0.570 |
Why?
|
| Cell Proliferation | 15 | 2022 | 10481 | 0.560 |
Why?
|
| Organogenesis | 1 | 2018 | 222 | 0.560 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2016 | 1097 | 0.560 |
Why?
|
| Bone Neoplasms | 6 | 2019 | 2529 | 0.560 |
Why?
|
| Imidazoles | 6 | 2017 | 1206 | 0.560 |
Why?
|
| Molecular Targeted Therapy | 5 | 2018 | 2727 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2015 | 2942 | 0.550 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2018 | 2455 | 0.550 |
Why?
|
| Laryngeal Neoplasms | 4 | 2021 | 512 | 0.550 |
Why?
|
| Genomics | 12 | 2021 | 5720 | 0.530 |
Why?
|
| Cell Line, Tumor | 23 | 2022 | 16689 | 0.530 |
Why?
|
| Neurons | 10 | 2022 | 9338 | 0.530 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2017 | 635 | 0.530 |
Why?
|
| Retinal Ganglion Cells | 4 | 2022 | 770 | 0.510 |
Why?
|
| Antineoplastic Agents | 13 | 2021 | 13695 | 0.510 |
Why?
|
| Genetic Engineering | 4 | 2015 | 951 | 0.510 |
Why?
|
| Histones | 5 | 2019 | 2599 | 0.510 |
Why?
|
| Cell Cycle Proteins | 12 | 2018 | 3462 | 0.500 |
Why?
|
| Immunotherapy | 4 | 2020 | 4445 | 0.500 |
Why?
|
| Mice, Knockout | 20 | 2022 | 14557 | 0.480 |
Why?
|
| Radiosurgery | 4 | 2021 | 1329 | 0.480 |
Why?
|
| Piperazines | 7 | 2017 | 2488 | 0.470 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 286 | 0.450 |
Why?
|
| Mice, Transgenic | 12 | 2022 | 9734 | 0.450 |
Why?
|
| Cell Lineage | 9 | 2022 | 2504 | 0.450 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 3479 | 0.440 |
Why?
|
| Chromatin | 6 | 2019 | 2934 | 0.440 |
Why?
|
| Oxazines | 1 | 2014 | 298 | 0.430 |
Why?
|
| Cell Death | 7 | 2014 | 1706 | 0.430 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2021 | 806 | 0.430 |
Why?
|
| Retinal Horizontal Cells | 1 | 2011 | 10 | 0.420 |
Why?
|
| Acetates | 2 | 2012 | 311 | 0.420 |
Why?
|
| DNA Methylation | 4 | 2021 | 4286 | 0.410 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2021 | 1736 | 0.410 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2019 | 5535 | 0.400 |
Why?
|
| Humans | 126 | 2023 | 744343 | 0.400 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 9274 | 0.400 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2011 | 85 | 0.400 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 11524 | 0.390 |
Why?
|
| Dendrites | 2 | 2011 | 485 | 0.390 |
Why?
|
| Radiation Oncology | 3 | 2021 | 555 | 0.380 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 514 | 0.370 |
Why?
|
| Body Patterning | 3 | 2015 | 626 | 0.360 |
Why?
|
| Globins | 5 | 1998 | 415 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2016 | 2915 | 0.360 |
Why?
|
| Melphalan | 1 | 2011 | 431 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.350 |
Why?
|
| Cebus | 1 | 2009 | 16 | 0.350 |
Why?
|
| Carboplatin | 2 | 2010 | 801 | 0.350 |
Why?
|
| Interneurons | 2 | 2007 | 577 | 0.350 |
Why?
|
| High-Throughput Screening Assays | 4 | 2018 | 944 | 0.350 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.350 |
Why?
|
| Aotidae | 1 | 2009 | 59 | 0.350 |
Why?
|
| RNA Splicing | 2 | 2022 | 907 | 0.340 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 3158 | 0.340 |
Why?
|
| Retroviridae | 3 | 2007 | 914 | 0.340 |
Why?
|
| Nervous System Neoplasms | 2 | 2011 | 91 | 0.330 |
Why?
|
| Pigmentation | 1 | 2009 | 148 | 0.330 |
Why?
|
| Ciliary Body | 1 | 2009 | 173 | 0.320 |
Why?
|
| Biological Evolution | 3 | 2016 | 1076 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2916 | 0.320 |
Why?
|
| Transcription Factors | 8 | 2022 | 12208 | 0.320 |
Why?
|
| Child | 29 | 2022 | 77709 | 0.320 |
Why?
|
| Medical Oncology | 2 | 2020 | 2265 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 19 | 2022 | 21827 | 0.320 |
Why?
|
| Galantamine | 1 | 2008 | 32 | 0.310 |
Why?
|
| Tissue Culture Techniques | 2 | 2006 | 290 | 0.310 |
Why?
|
| Gene Silencing | 3 | 2014 | 1538 | 0.310 |
Why?
|
| Laryngectomy | 2 | 2020 | 248 | 0.300 |
Why?
|
| Genes, myc | 2 | 2011 | 399 | 0.300 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2011 | 627 | 0.300 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1813 | 0.300 |
Why?
|
| Retinoblastoma-Like Protein p107 | 4 | 2009 | 74 | 0.300 |
Why?
|
| Pyrazoles | 3 | 2017 | 1972 | 0.300 |
Why?
|
| Gene Amplification | 4 | 2020 | 1063 | 0.300 |
Why?
|
| Interferon-beta | 1 | 2009 | 323 | 0.300 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 5 | 2008 | 323 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2009 | 2849 | 0.280 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2008 | 238 | 0.280 |
Why?
|
| Neural Crest | 2 | 2022 | 275 | 0.280 |
Why?
|
| Optic Nerve | 1 | 2009 | 554 | 0.270 |
Why?
|
| Anus Neoplasms | 2 | 2021 | 332 | 0.270 |
Why?
|
| Neuroglia | 2 | 2022 | 927 | 0.260 |
Why?
|
| Mutation | 19 | 2021 | 29786 | 0.260 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2001 | 1086 | 0.260 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2004 | 46 | 0.260 |
Why?
|
| Radiotherapy Dosage | 7 | 2023 | 2879 | 0.260 |
Why?
|
| DNA Repair | 1 | 2014 | 2046 | 0.260 |
Why?
|
| Cell Nucleus | 6 | 2020 | 2969 | 0.250 |
Why?
|
| Genetics | 1 | 2005 | 112 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4838 | 0.250 |
Why?
|
| Combined Modality Therapy | 4 | 2023 | 8642 | 0.250 |
Why?
|
| Cyclins | 3 | 2003 | 603 | 0.250 |
Why?
|
| Brachytherapy | 2 | 2023 | 1248 | 0.240 |
Why?
|
| Electroporation | 1 | 2006 | 251 | 0.240 |
Why?
|
| RNA, Messenger | 4 | 2014 | 13033 | 0.240 |
Why?
|
| Genetic Vectors | 3 | 2009 | 3420 | 0.240 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1462 | 0.240 |
Why?
|
| Dependovirus | 1 | 2009 | 706 | 0.240 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1224 | 0.230 |
Why?
|
| Neoplasm Staging | 9 | 2023 | 11031 | 0.230 |
Why?
|
| Age of Onset | 2 | 2012 | 3271 | 0.230 |
Why?
|
| Biomedical Research | 3 | 2020 | 3309 | 0.230 |
Why?
|
| Cell Line | 9 | 2021 | 15997 | 0.230 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1866 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 8863 | 0.220 |
Why?
|
| Gene Expression Profiling | 9 | 2022 | 9438 | 0.220 |
Why?
|
| Exons | 2 | 2021 | 2437 | 0.220 |
Why?
|
| Pediatrics | 2 | 2015 | 3475 | 0.220 |
Why?
|
| Camptothecin | 2 | 2017 | 576 | 0.220 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 70 | 0.210 |
Why?
|
| Pyridines | 1 | 2014 | 2825 | 0.210 |
Why?
|
| Female | 44 | 2023 | 380194 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1341 | 0.210 |
Why?
|
| Eye Proteins | 6 | 2014 | 646 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 4 | 2003 | 50 | 0.200 |
Why?
|
| Melanoma | 3 | 2015 | 5510 | 0.200 |
Why?
|
| Interleukin-2 | 2 | 2019 | 1904 | 0.200 |
Why?
|
| Indoles | 2 | 2021 | 1839 | 0.200 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2021 | 121 | 0.190 |
Why?
|
| Apoptosis | 4 | 2015 | 9727 | 0.190 |
Why?
|
| DNA Copy Number Variations | 4 | 2021 | 1941 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1169 | 0.190 |
Why?
|
| Species Specificity | 3 | 2013 | 2478 | 0.190 |
Why?
|
| Vincristine | 2 | 2017 | 1039 | 0.190 |
Why?
|
| Mice, Nude | 5 | 2021 | 3689 | 0.190 |
Why?
|
| Mice, Inbred ICR | 4 | 2001 | 352 | 0.180 |
Why?
|
| Amacrine Cells | 1 | 2020 | 53 | 0.180 |
Why?
|
| Muscle Development | 1 | 2022 | 271 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2009 | 8301 | 0.180 |
Why?
|
| Small Molecule Libraries | 3 | 2019 | 720 | 0.180 |
Why?
|
| Rats | 9 | 2010 | 24260 | 0.180 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 2085 | 0.180 |
Why?
|
| Drug Synergism | 3 | 2021 | 1792 | 0.180 |
Why?
|
| Mice, SCID | 2 | 2018 | 2716 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2018 | 1915 | 0.180 |
Why?
|
| Nuclear Lamina | 1 | 2019 | 46 | 0.180 |
Why?
|
| Repressor Proteins | 4 | 2019 | 3023 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5867 | 0.180 |
Why?
|
| Prisoners | 1 | 2023 | 297 | 0.180 |
Why?
|
| Gliosis | 1 | 2000 | 245 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6314 | 0.170 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 2183 | 0.170 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1678 | 0.170 |
Why?
|
| Vision, Ocular | 1 | 2022 | 464 | 0.170 |
Why?
|
| Telomere | 2 | 2017 | 910 | 0.170 |
Why?
|
| Glottis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Transgenes | 2 | 2015 | 1009 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.160 |
Why?
|
| Morpholines | 1 | 2021 | 571 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2012 | 375 | 0.160 |
Why?
|
| Genome, Human | 5 | 2021 | 4420 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 5686 | 0.160 |
Why?
|
| Central Nervous System | 1 | 2005 | 1357 | 0.150 |
Why?
|
| Models, Biological | 6 | 2012 | 9583 | 0.150 |
Why?
|
| Drug Discovery | 2 | 2016 | 1058 | 0.150 |
Why?
|
| Co-Repressor Proteins | 2 | 2017 | 194 | 0.150 |
Why?
|
| Pyrimidines | 2 | 2021 | 2942 | 0.150 |
Why?
|
| Glycine | 1 | 2001 | 671 | 0.150 |
Why?
|
| High Mobility Group Proteins | 1 | 1998 | 187 | 0.150 |
Why?
|
| Disease Progression | 6 | 2014 | 13284 | 0.150 |
Why?
|
| Regenerative Medicine | 2 | 2022 | 307 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 212 | 0.150 |
Why?
|
| Erythroid Precursor Cells | 1 | 1998 | 218 | 0.150 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 523 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 15519 | 0.150 |
Why?
|
| Pathology, Molecular | 1 | 2020 | 326 | 0.150 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 4 | 2023 | 1624 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2015 | 1270 | 0.150 |
Why?
|
| Muscle Neoplasms | 1 | 2018 | 139 | 0.150 |
Why?
|
| Conjunctiva | 2 | 2011 | 494 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 6 | 2015 | 4803 | 0.150 |
Why?
|
| Embryonic Stem Cells | 2 | 2015 | 1294 | 0.150 |
Why?
|
| Transcriptional Elongation Factors | 1 | 1998 | 166 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.140 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 6489 | 0.140 |
Why?
|
| Drug Repositioning | 1 | 2018 | 229 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2004 | 5021 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 10943 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 163 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2021 | 6538 | 0.140 |
Why?
|
| Adult | 21 | 2021 | 214055 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2015 | 3144 | 0.140 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1284 | 0.140 |
Why?
|
| Tretinoin | 2 | 2018 | 517 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2022 | 1609 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 789 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 903 | 0.140 |
Why?
|
| Male | 33 | 2023 | 350118 | 0.140 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 6993 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2109 | 0.130 |
Why?
|
| Microphthalmos | 1 | 2015 | 54 | 0.130 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 452 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2003 | 4462 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2006 | 2972 | 0.130 |
Why?
|
| Antipsychotic Agents | 2 | 2008 | 3057 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2001 | 1125 | 0.130 |
Why?
|
| E2F3 Transcription Factor | 1 | 2014 | 40 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 4034 | 0.130 |
Why?
|
| Pyrimidinones | 1 | 2017 | 371 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2016 | 670 | 0.130 |
Why?
|
| Loss of Heterozygosity | 3 | 2015 | 684 | 0.130 |
Why?
|
| Hepatoblastoma | 1 | 2015 | 87 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2001 | 1121 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 871 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2017 | 494 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2014 | 190 | 0.120 |
Why?
|
| Antigens, Neoplasm | 2 | 2022 | 1988 | 0.120 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 88 | 0.120 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1878 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
| Base Sequence | 11 | 2019 | 12797 | 0.120 |
Why?
|
| Haplorhini | 2 | 2006 | 552 | 0.120 |
Why?
|
| Clone Cells | 1 | 2017 | 1692 | 0.120 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 215 | 0.120 |
Why?
|
| Survival Rate | 6 | 2021 | 12788 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2015 | 417 | 0.120 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1758 | 0.120 |
Why?
|
| Child, Preschool | 10 | 2021 | 41006 | 0.120 |
Why?
|
| Embryo, Mammalian | 5 | 2006 | 1701 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2008 | 4043 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 437 | 0.110 |
Why?
|
| Neoplasms, Experimental | 2 | 2010 | 1276 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1788 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 1620 | 0.110 |
Why?
|
| DNA Primers | 2 | 2012 | 2892 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 162 | 0.110 |
Why?
|
| Ribonuclease III | 2 | 2012 | 275 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 11366 | 0.110 |
Why?
|
| Genes, Neoplasm | 1 | 2015 | 376 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 1583 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2014 | 318 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 440 | 0.110 |
Why?
|
| Infant | 8 | 2021 | 35136 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1018 | 0.110 |
Why?
|
| Cisplatin | 1 | 2019 | 1662 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1970 | 0.110 |
Why?
|
| Pneumocystis | 1 | 1992 | 57 | 0.110 |
Why?
|
| Karnofsky Performance Status | 1 | 2012 | 173 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2021 | 1099 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 2765 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 742 | 0.100 |
Why?
|
| Mesoderm | 2 | 2014 | 686 | 0.100 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 13102 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2077 | 0.100 |
Why?
|
| Gene Expression | 4 | 2015 | 7799 | 0.100 |
Why?
|
| Phthalazines | 1 | 2014 | 363 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1938 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3798 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 193 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2006 | 2726 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2021 | 7729 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2001 | 2072 | 0.100 |
Why?
|
| Dacarbazine | 1 | 2014 | 566 | 0.100 |
Why?
|
| Pneumonectomy | 1 | 2018 | 1094 | 0.100 |
Why?
|
| Ophthalmic Artery | 1 | 2011 | 60 | 0.100 |
Why?
|
| Cranial Irradiation | 1 | 2014 | 401 | 0.100 |
Why?
|
| Binding Sites | 3 | 2017 | 6114 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 436 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 509 | 0.100 |
Why?
|
| Middle Aged | 18 | 2023 | 213383 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2001 | 2924 | 0.100 |
Why?
|
| Embryonic and Fetal Development | 3 | 2001 | 438 | 0.100 |
Why?
|
| Smoking | 1 | 2008 | 8987 | 0.100 |
Why?
|
| E2F Transcription Factors | 2 | 2014 | 277 | 0.100 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 184 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.090 |
Why?
|
| Epitopes | 1 | 2017 | 2571 | 0.090 |
Why?
|
| Pons | 1 | 2012 | 245 | 0.090 |
Why?
|
| Cell Count | 2 | 2007 | 1856 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2017 | 2564 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1928 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 9648 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2020 | 63114 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2009 | 3616 | 0.090 |
Why?
|
| Schizophrenic Psychology | 2 | 2008 | 1678 | 0.090 |
Why?
|
| Developmental Biology | 1 | 2011 | 76 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5221 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2014 | 594 | 0.090 |
Why?
|
| Aged | 14 | 2021 | 163280 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 712 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1213 | 0.090 |
Why?
|
| Brain Stem Neoplasms | 1 | 2012 | 204 | 0.090 |
Why?
|
| Telomerase | 1 | 2014 | 730 | 0.090 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 4186 | 0.090 |
Why?
|
| Solubility | 1 | 2011 | 1085 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2014 | 850 | 0.090 |
Why?
|
| Protein Binding | 7 | 2017 | 9386 | 0.080 |
Why?
|
| Catheters | 2 | 2023 | 425 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2008 | 6882 | 0.080 |
Why?
|
| Hospitals | 1 | 2023 | 3952 | 0.080 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 4851 | 0.080 |
Why?
|
| Cell Survival | 2 | 2012 | 5882 | 0.080 |
Why?
|
| MicroRNAs | 3 | 2014 | 3752 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 2382 | 0.080 |
Why?
|
| Students, Medical | 1 | 2021 | 1862 | 0.080 |
Why?
|
| Tubulin | 1 | 1992 | 695 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2012 | 530 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23403 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2009 | 229 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 4042 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1782 | 0.080 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2017 | 730 | 0.080 |
Why?
|
| Prognosis | 6 | 2016 | 29063 | 0.080 |
Why?
|
| Time Factors | 5 | 2019 | 40075 | 0.070 |
Why?
|
| Genotype | 2 | 2012 | 12951 | 0.070 |
Why?
|
| Transfection | 2 | 2014 | 5892 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2001 | 4217 | 0.070 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 12354 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39050 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 90 | 0.070 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2007 | 104 | 0.070 |
Why?
|
| Proteins | 2 | 2003 | 6103 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2003 | 829 | 0.070 |
Why?
|
| Mitochondria | 1 | 2020 | 3520 | 0.070 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 413 | 0.070 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 18111 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 795 | 0.070 |
Why?
|
| Anterior Chamber | 1 | 2007 | 197 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2503 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77449 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2006 | 191 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2924 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2008 | 463 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 17446 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2569 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2013 | 1023 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1660 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 1903 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 1708 | 0.060 |
Why?
|
| Vitreous Body | 1 | 2007 | 389 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1861 | 0.060 |
Why?
|
| Chimera | 1 | 2006 | 485 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1703 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 271 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1596 | 0.060 |
Why?
|
| Neurites | 1 | 2007 | 388 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2020 | 25625 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 20822 | 0.060 |
Why?
|
| Cadherins | 1 | 2009 | 907 | 0.060 |
Why?
|
| Gastrula | 2 | 2003 | 84 | 0.060 |
Why?
|
| Choristoma | 1 | 2006 | 213 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 331 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 4320 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4751 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 302 | 0.060 |
Why?
|
| DNA | 4 | 2015 | 7301 | 0.060 |
Why?
|
| Endoderm | 2 | 2003 | 154 | 0.060 |
Why?
|
| Etoposide | 1 | 2005 | 641 | 0.060 |
Why?
|
| Critical Illness | 1 | 1997 | 2670 | 0.060 |
Why?
|
| Sample Size | 1 | 2007 | 845 | 0.060 |
Why?
|
| Organ Size | 1 | 2009 | 2252 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4420 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
| United States | 5 | 2023 | 69872 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 1997 | 3679 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2018 | 5102 | 0.060 |
Why?
|
| Cyclin D | 1 | 2003 | 71 | 0.060 |
Why?
|
| Cell Movement | 1 | 2015 | 5217 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 898 | 0.060 |
Why?
|
| Placebos | 1 | 2008 | 1676 | 0.060 |
Why?
|
| Disease Management | 1 | 2014 | 2459 | 0.060 |
Why?
|
| Electroretinography | 1 | 2004 | 509 | 0.060 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2022 | 36 | 0.050 |
Why?
|
| Xenopus | 2 | 2003 | 712 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 643 | 0.050 |
Why?
|
| Computational Biology | 3 | 2021 | 3521 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21746 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3086 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2019 | 3494 | 0.050 |
Why?
|
| Adolescent | 10 | 2021 | 85781 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 7913 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2021 | 5974 | 0.050 |
Why?
|
| Nicotine | 1 | 2007 | 681 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 40561 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2003 | 286 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 13881 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2007 | 2751 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2003 | 244 | 0.050 |
Why?
|
| Phylogeny | 1 | 2009 | 2803 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8037 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1730 | 0.050 |
Why?
|
| Visual Acuity | 1 | 2010 | 2530 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2009 | 2740 | 0.050 |
Why?
|
| Oncogenes | 1 | 2007 | 1265 | 0.050 |
Why?
|
| Genomic Instability | 2 | 2016 | 695 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2021 | 5788 | 0.050 |
Why?
|
| Naphthyridines | 1 | 2021 | 118 | 0.050 |
Why?
|
| Retinal Dysplasia | 1 | 2000 | 15 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 895 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2001 | 149 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2014 | 3479 | 0.050 |
Why?
|
| Cyclin D3 | 1 | 2000 | 55 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1549 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4443 | 0.050 |
Why?
|
| Nervous System | 1 | 2004 | 554 | 0.050 |
Why?
|
| Macrophages | 1 | 2015 | 5655 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2021 | 248 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2021 | 5179 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2014 | 19229 | 0.050 |
Why?
|
| Attention | 2 | 2008 | 2400 | 0.050 |
Why?
|
| Young Adult | 7 | 2021 | 56430 | 0.050 |
Why?
|
| Electron Transport | 1 | 2020 | 211 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 12072 | 0.040 |
Why?
|
| Retinal Artery | 1 | 2000 | 111 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5708 | 0.040 |
Why?
|
| Freezing | 1 | 2020 | 303 | 0.040 |
Why?
|
| Parasitology | 1 | 1999 | 29 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 250 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2005 | 683 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2022 | 302 | 0.040 |
Why?
|
| Needles | 1 | 2022 | 449 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 1142 | 0.040 |
Why?
|
| Medulloblastoma | 1 | 2004 | 683 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16365 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 433 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 6622 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 360 | 0.040 |
Why?
|
| Guanosine | 1 | 1998 | 61 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1586 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1432 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 386 | 0.040 |
Why?
|
| Memory | 1 | 2008 | 2174 | 0.040 |
Why?
|
| Cell Separation | 1 | 2004 | 1751 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2008 | 6459 | 0.040 |
Why?
|
| Cerebellum | 1 | 2005 | 1488 | 0.040 |
Why?
|
| Blindness | 1 | 2022 | 617 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2212 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 1950 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 1999 | 208 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 57776 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 99 | 0.040 |
Why?
|
| Malaria, Vivax | 1 | 1999 | 173 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 2505 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2019 | 1526 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2023 | 853 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 1997 | 35 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2708 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 671 | 0.040 |
Why?
|
| 3' Flanking Region | 1 | 2016 | 15 | 0.040 |
Why?
|
| DNA Damage | 1 | 2006 | 2432 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2012 | 3481 | 0.040 |
Why?
|
| Ecosystem | 1 | 2021 | 474 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 233 | 0.030 |
Why?
|
| Protein Methyltransferases | 1 | 2016 | 55 | 0.030 |
Why?
|
| Mentors | 1 | 2021 | 631 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2020 | 2645 | 0.030 |
Why?
|
| Ohio | 1 | 1997 | 337 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 783 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2010 | 6196 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1998 | 841 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2016 | 4011 | 0.030 |
Why?
|
| Calibration | 1 | 2018 | 816 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 12245 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 407 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10252 | 0.030 |
Why?
|
| Erythrocytes | 2 | 1996 | 2455 | 0.030 |
Why?
|
| Alphapapillomavirus | 1 | 2018 | 221 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3701 | 0.030 |
Why?
|
| Mitosis | 1 | 2000 | 1208 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 25 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1997 | 571 | 0.030 |
Why?
|
| Semaphorins | 1 | 2015 | 101 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2019 | 1266 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2014 | 58 | 0.030 |
Why?
|
| Microscopy | 1 | 2020 | 903 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1085 | 0.030 |
Why?
|
| Larynx | 1 | 2019 | 494 | 0.030 |
Why?
|
| Kinetics | 2 | 2020 | 6473 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2014 | 151 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 585 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2480 | 0.030 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2014 | 67 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2015 | 271 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 504 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 3002 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 1997 | 372 | 0.030 |
Why?
|
| Pliability | 1 | 2012 | 63 | 0.030 |
Why?
|
| Buffers | 1 | 2012 | 147 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1799 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 655 | 0.030 |
Why?
|
| Nevus, Pigmented | 1 | 2014 | 219 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2559 | 0.030 |
Why?
|
| HIV Infections | 1 | 2018 | 16718 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.030 |
Why?
|
| Propensity Score | 1 | 2019 | 1781 | 0.030 |
Why?
|
| Aging | 1 | 2011 | 8664 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1791 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 1775 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 1723 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 893 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 459 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 748 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2000 | 1210 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 705 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 12959 | 0.020 |
Why?
|
| Malaria, Falciparum | 1 | 1999 | 1077 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1992 | 280 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 970 | 0.020 |
Why?
|
| COS Cells | 2 | 2003 | 1161 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 547 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 557 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2010 | 2327 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 7722 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3912 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3129 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13815 | 0.020 |
Why?
|
| Biological Availability | 1 | 2010 | 397 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1059 | 0.020 |
Why?
|
| Cognition | 1 | 2007 | 6770 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1060 | 0.020 |
Why?
|
| Medicaid | 1 | 2023 | 2736 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 1999 | 1732 | 0.020 |
Why?
|
| Pregnancy | 3 | 2006 | 29144 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 7785 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 26385 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 1252 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2015 | 2634 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1420 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7322 | 0.020 |
Why?
|
| Cattle | 2 | 2003 | 3922 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 1808 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1994 | 1381 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 6171 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 2206 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3505 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5456 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
| Leukemia | 1 | 1994 | 1511 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2010 | 1124 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3760 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2889 | 0.020 |
Why?
|
| Alleles | 2 | 2007 | 6933 | 0.020 |
Why?
|
| Conserved Sequence | 2 | 2002 | 1202 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 1997 | 3703 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3638 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1375 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 711 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 2 | 2007 | 1376 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2007 | 675 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 53288 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18370 | 0.010 |
Why?
|
| Length of Stay | 1 | 1997 | 6309 | 0.010 |
Why?
|
| Haplotypes | 1 | 2009 | 2779 | 0.010 |
Why?
|
| Bronchi | 1 | 2007 | 840 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3586 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 4256 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 3913 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3340 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
| Yeasts | 1 | 2003 | 285 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 9856 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 2029 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3386 | 0.010 |
Why?
|
| Homozygote | 1 | 2006 | 1785 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2006 | 707 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 13989 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2002 | 982 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 303 | 0.010 |
Why?
|
| Fetal Development | 1 | 2006 | 767 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4409 | 0.010 |
Why?
|
| Chromatography | 1 | 1999 | 206 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 936 | 0.010 |
Why?
|
| Indonesia | 1 | 1999 | 119 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1901 | 0.010 |
Why?
|
| Liver | 1 | 1994 | 7474 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6365 | 0.010 |
Why?
|
| Naphthol AS D Esterase | 1 | 1997 | 14 | 0.010 |
Why?
|
| Risk Factors | 2 | 2018 | 72290 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 6038 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 1114 | 0.010 |
Why?
|
| Developing Countries | 1 | 2008 | 2815 | 0.010 |
Why?
|
| Immunoassay | 1 | 1999 | 752 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.010 |
Why?
|
| Quality of Life | 1 | 1997 | 12804 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1997 | 927 | 0.010 |
Why?
|
| Intestines | 1 | 2003 | 1924 | 0.010 |
Why?
|
| Peroxidase | 1 | 1997 | 611 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1997 | 707 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 803 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12026 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 1993 | 378 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 1880 | 0.010 |
Why?
|
| Primates | 1 | 1994 | 545 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 15226 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1994 | 755 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1993 | 705 | 0.010 |
Why?
|
| Rabbits | 1 | 1994 | 4894 | 0.000 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1519 | 0.000 |
Why?
|
| Acute Disease | 1 | 1997 | 7149 | 0.000 |
Why?
|